Meeting
2020 ASCO Virtual Scientific Program
Quality of life, vascular endothelial growth factor inhibition, and survival outcomes with combination oral metronomic therapy in platinum refractory epithelial ovarian carcinoma: Results from a randomized study.
Authors
Aparna Sharma
Dr. B.R. A. IRCH, All India Institute of Medical Sciences, Delhi, India
Aparna Sharma , Sachin Khurana , Prabhat Singh Malik , Mayank Singh , Sandeep Mathur , Sunesh Kumar , Vishnu kumar Sreenivas , Lalit Kumar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Clinical Trial Registration Number
CTRI/2017/10/010219
Citation
J Clin Oncol 38: 2020 (suppl; abstr 6048)
DOI
10.1200/JCO.2020.38.15_suppl.6048
Abstract #
6048
Poster Bd #
219
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Neurofilament light chains: A biomarker for vincristine-related neuropathy.
First Author: Gretchen A McNally
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2021 ASCO Annual Meeting
Changes in patient-reported outcomes (PROs) and tumor markers (TMs) to predict treatment response and survival outcomes in patients with metastatic gastrointestinal (GI) cancer.
First Author: Joy X. Jarnagin
Poster
2014 ASCO Annual Meeting
Association of hand-foot syndrome (HFS), treatment dose reductions (TDRs), and outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).
First Author: Erin B. Bailey